MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Você também pode gostar
Ganhadores
Últimas notícias sobre cripto
Fed Futuras Reuniões Risco Vendo Incremento de Disputas Aumentando a Volatilidade do Mercado
Tom Lee: BTC e ETH Ratio Risk-Reward se tornando bastante atraente
O Coinbase agora está ao vivo com a negociação spot da Rayls (RLS)
Um determinado endereço de baleia depositou 10 milhões U em HyperLiquid, iniciando uma posição 20x ETH longa.
Coinbase to List Rayls (RLS)
Atendimento ao cliente:@weikecs
Parcerias comerciais:@weikecs
Quant trading e MM:[email protected]
Serviços VIP:[email protected]